tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Palvella Therapeutics (PVLA)
NASDAQ:PVLA
US Market
PVLA
Palvella Therapeutics
RESEARCH TOOLSreports

Palvella Therapeutics (PVLA) Stock News & Sentiment

Compare
694 Followers
Buy Rating Affirmed for Palvella Therapeutics Following Promising Phase 2 TOIVA Trial Results
Premium
Ratings
Buy Rating Affirmed for Palvella Therapeutics Following Promising Phase 2 TOIVA Trial Results
4d ago
PVLA
Promising Clinical Data and Market Potential Drive Buy Rating for Palvella Therapeutics’ QTORIN Rapamycin
Premium
Ratings
Promising Clinical Data and Market Potential Drive Buy Rating for Palvella Therapeutics’ QTORIN Rapamycin
5d ago
PVLA
Palvella Therapeutics Reports Positive Phase 2 Study Results
Premium
Company Announcements
Palvella Therapeutics Reports Positive Phase 2 Study Results
5d ago
8K
PVLA
Positive Buy Rating for Palvella Therapeutics Driven by Promising Developments in DSAP Treatment
Premium
Ratings
Positive Buy Rating for Palvella Therapeutics Driven by Promising Developments in DSAP Treatment
15d ago
PVLA
Palvella Therapeutics: Promising Biopharmaceutical Growth with QTORIN Platform Advancements
Premium
Ratings
Palvella Therapeutics: Promising Biopharmaceutical Growth with QTORIN Platform Advancements
15d ago
PVLA
Palvella Therapeutics: Strategic Advancements and Promising Pipeline Drive Buy Rating
Premium
Ratings
Palvella Therapeutics: Strategic Advancements and Promising Pipeline Drive Buy Rating
1M ago
PVLA
Buy Rating Affirmed for Palvella Therapeutics: QTORIN Platform Expansion and Potential FDA Approval Drive Optimism
Premium
Ratings
Buy Rating Affirmed for Palvella Therapeutics: QTORIN Platform Expansion and Potential FDA Approval Drive Optimism
1M ago
PVLA
More PVLA News >

PVLA News on the Web

The $100 Club - Were You Early To The Triple-Digit Rally In ABVX, NUTX, BLTE…?
rttnews
Neutral
Palvella: FDA Grants Fast Track Designation For QTORIN Rapamycin In Angiokeratomas
rttnews
Neutral
Palvella Therapeutics (PVLA) Gets a Buy from Canaccord Genuity
TipRanks News
Neutral
Why Palvella Therapeutics, Inc.’s (PVLA) Stock Is Up 6.13%
AAII
Neutral
Palvella Therapeutics Reports Positive Phase 2 Results For QTORIN Rapamycin Gel
rttnews
Neutral
Why Palvella Therapeutics, Inc.’s (PVLA) Stock Is Down 11.47%
AAII
Neutral
Why Palvella Therapeutics, Inc.’s (PVLA) Stock Is Up 5.01%
AAII
Neutral
Why Palvella Therapeutics, Inc.’s (PVLA) Stock Is Down 7.26%
AAII
Neutral

News Score - Last 7 Days

Neutral
PVLA
Sector Average
Media Buzz
This Week6 articles
Weekly Average3 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PVLA’s Media Buzz Sentiment?
6 articles about PVLA were published this week. In an average week, 3 articles are published.
    What is PVLA’s weekly average amount of articles?
    In an average week, 3 articles about PVLA are published.
      What is PVLA’s News Sentiment?
      50% of articles about PVLA were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        CYTKCytokinetics
        KYTXKyverna Therapeutics, Inc.
        ANIPANI Pharmaceuticals
        HIKHikma Pharmaceuticals
        DBVTDBV Technologies SA - American
        Showing the stocks with the most bullish news sentiment over the past week